Immuno-oncology: Servier and Aqemia cooperate on AI and quantum physics-driven drug discovery
All the news from Servier Group
Servier joins the Act4Nature International Initiative
Servier invests 100 million euros in a new production unit at its Oril Industrie site
Egis inaugurates two new plants in Körmend
World Pancreatic Cancer Day: Servier strives to make progress in cancer treatments
World Diabetes Day: promoting prevention, treatment, and care of diabetes
Immuno-oncology: Servier and Pieris announce dosing of first patient in phase 1/2 trial
World Mental Health Day: a public health priority
Neurodegenerative diseases: Servier enter into a new research collaboration